1. Academic Validation
  2. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice

Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice

  • Nat Immunol. 2005 Oct;6(10):1047-53. doi: 10.1038/ni1247.
Baohua Zhou 1 Michael R Comeau Thibaut De Smedt H Denny Liggitt Martin E Dahl David B Lewis Dora Gyarmati Theingi Aye Daniel J Campbell Steven F Ziegler
Affiliations

Affiliation

  • 1 Immunology Program, Benaroya Research Institute, Seattle, Washington 98101, USA.
Abstract

The cytokine thymic stromal lymphopoietin (TSLP) has been linked to human allergic inflammatory diseases. We show here that TSLP expression was increased in the lungs of mice with antigen-induced asthma, whereas TSLP receptor-deficient mice had considerably attenuated disease. Lung-specific expression of a Tslp transgene induced airway inflammation and hyperreactivity characterized by T helper type 2 cytokines and increased immunoglobulin E. The lungs of Tslp-transgenic mice showed massive infiltration of leukocytes, goblet cell hyperplasia and subepithelial fibrosis. TSLP was capable of activating bone marrow-derived dendritic cells to upregulate costimulatory molecules and produce the T helper type 2 cell-attracting chemokine CCL17. These findings suggest that TSLP is an important factor necessary and sufficient for the initiation of allergic airway inflammation.

Figures